SPC, MSD before COPE


The State Pharmaceutical Corporation (SPC) and the Medical Supplies Division (MSD) of the Ministry of Health have been summoned before the Committee on Public Enterprises (COPE) today (31).

Accordingly, the officials will appear before COPE at 10.00 a.m.

These institutions have been summoned before COPE to inquire into the current performance.

Meanwhile, it was revealed in the most recent report of the Committee on Public Accounts (COPA) Rs 6.25 billion worth of medicinal drugs had failed quality tests, from 2011 to 2020, due to improper storage and 99 per cent of the drugs had already been given to patients at the time this situation was brought to the attention of the authorities. In this situation, it is not possible to recover the cost of drugs which were of poor quality from the suppliers.

It has been also observed that the temperature in warehouses owned by the Medical Supplies Division was not maintained properly and that the medical supplies were stored in the corridors of central drug warehouses and hospitals.

Furthermore, the former Secretary to the Health Ministry had pointed out that if there was a system to detect the failure of the drug as soon as it is received, the loss could be recovered from the suppliers’ guarantee and if quality testing of 60 drugs could be done by the SPC this situation can be avoided to some extent.